MESDC2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 8.32667268468867E-15 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.2113999803276E-09 |
Normal-vs-Stage2 |
1.29879999999361E-06 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
5.497200E-03 |
Stage1-vs-Stage2 |
7.892800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
3.552400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
3.038800E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.42603723169077E-12 |
Normal-vs-AfricanAmerican |
1.447400E-01 |
Normal-vs-Asian |
3.225800E-02 |
Caucasian-vs-AfricanAmerican |
4.090200E-01 |
Caucasian-vs-Asian |
3.968200E-01 |
AfricanAmerican-vs-Asian |
9.042200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.85219997304176E-09 |
Normal-vs-Female |
2.48949999503978E-08 |
Male-vs-Female |
1.025800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.151720E-04 |
Normal-vs-Extreme_Weight |
2.79590000040741E-08 |
Normal-vs-Obese |
4.903300E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
9.897200E-01 |
Normal_Weight-vs-Obese |
5.887200E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
5.968400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.965600E-01 |
Normal-vs-Age(41-60Yrs) |
1.36609999978887E-07 |
Normal-vs-Age(61-80Yrs) |
6.7167005290969E-10 |
Normal-vs-Age(81-100Yrs) |
1.3320999999733E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.855800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.035000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.275400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.824200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.116000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.313000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
6.780600E-01 |
Normal-vs-Grade 3 |
7.055200E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.351600E-01 |
Grade 2-vs-Grade 4 |
6.780600E-01 |
Grade 3-vs-Grade 4 |
7.055200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.1129764604666E-12 |
Normal-vs-N1 |
1.844050E-02 |
N0-vs-N1 |
2.166000E-01 |
|
|